Showing results (61-70 of 283) with videos related to
Sort By:
Pageof 29
Surgical Case Reports|August 24, 2017
Aggressive angiomyxoma of the liver: a case report and literature reviewKoki Sato, Masahiro Ohira, Seiichi Shimizu, et al.Hepatology (Baltimore, Md.)|March 25, 2018
Acute hepatitis B virus infection in humanized chimeric mice has multiphasic viral kineticsYuji Ishida, Tje Lin Chung, Michio Imamura, et al.Journal of Virology|August 7, 2015
Human Cytotoxic T Lymphocyte-Mediated Acute Liver Failure and Rescue by Immunoglobulin in Human Hepatocyte Transplant TK-NOG MiceTakuro Uchida, Nobuhiko Hiraga, Michio Imamura, et al.Journal of Hepatology|December 15, 2010
IL28 variation affects expression of interferon stimulated genes and peg-interferon and ribavirin therapyHiromi Abe, C Nelson Hayes, Hidenori Ochi, et al.Plos One|June 18, 2015
Rapid, Sensitive, and Accurate Evaluation of Drug Resistant Mutant (NS5A-Y93H) Strain Frequency in Genotype 1b HCV by Invader AssaySatoshi Yoshimi, Hidenori Ochi, Eisuke Murakami, et al.Antiviral Therapy|July 28, 2012
Identification of novel HCV deletion mutants in chronic hepatitis C patientsTomohiko Kohno, Masataka Tsuge, C Nelson Hayes, et al.Journal of Gastroenterology|February 12, 2013
Serum HBV RNA and HBeAg are useful markers for the safe discontinuation of nucleotide analogue treatments in chronic hepatitis B patientsMasataka Tsuge, Eisuke Murakami, Michio Imamura, et al.Clinical Journal of Gastroenterology|July 18, 2015
A second attack of cholestasis associated with erythropoietic protoporphyria was successfully treated by plasma exchange and blood transfusionYohji Honda, Yoshiiku Kawakami, Hiromi Kan, et al.The Journal of Infectious Diseases|May 5, 2020
Modeling-Based Response-Guided Glecaprevir-Pibrentasvir Therapy for Chronic Hepatitis C to Identify Patients for Ultrashort Treatment DurationSwikriti Dasgupta, Michio Imamura, Evan Gorstein, et al.Hepatology Research : the Official Journal of the Japan Society of Hepatology|March 19, 2016
Complete response to short-term sorafenib treatment alone for hepatocellular carcinoma with bone, lymph node, and peritoneum metastasesNorihito Nakano, Tomokazu Kawaoka, Hiroshi Aikata, et al.Pageof 29